SSAT054: Non-genetic factors in the pathogenesis of IBD in Twins

• Research type

  Research Study

• Full title

  SSAT 054: Study of non-genetic factors in the pathogenesis of Inflammatory Bowel Disease in Twins

• IRAS ID

  143263

• Contact name

  Hannah Gordon

• Contact email

  hannahgordon@doctors.org.uk

• Sponsor organisation

  St Stephen's AIDS Trust

• Duration of Study in the UK

  2 years, 0 months, 0 days

• Research summary

  Background: The inflammatory bowel diseases (IBD), Crohn's Disease (CD) and Ulcerative Colitis (UC), are debilitating conditions with a complex aetiology. The biggest risk factor for developing IBD is having an affected first degree relative. However when an identical twin is diagnosed with IBD, the other twin goes on to develop the condition in only 20-55% of cases.

  Recent research suggests the microbiota - the ecosystem of bacteria within the gut - may trigger disease in susceptible individuals. Another important research area is the epigenome - changes to the structure and regulation of our genome which occur throughout our life. It is known that siblings of Crohn's Disease sufferers have a changes to the immune system characteristic of Crohn's. However it is not known whether these changes are due to genetic similarity or shared environment.

  Comparison between mono and dizygotic twins elucidates the relative importance of genetic and environmental factors.

  Primary Objective: An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease.

  Study Design: Multicentre basic science study involving human participants

  Planned sample size: 200 data subjects (100 twin pairs)

  Methodology:
  A) Identification of twin pairs where one or both have inflammatory bowel disease via:
  1) IBD Nixon Twin and Multiplex Registry.
  2) Advertising for twin pairs via BSG website and newsletters/patient support groups/social media sites/clinic posters.
  3) Identification by study sites
  B) Obtaining formal written consent
  C) Collection of blood, stool and urine.
  D) The following analysis will be carried out:
  • Epigenetics (blood) - DNA extraction and subsequent methylation analysis and bisulphate conversion with 450 Illumina beadchip assay
  • Functional immunology (blood) – flow cytometry of CD3, CD4 and CD8 cells. (London Twin pairs discordant for Crohn’s Disease)
  • 16S rRNA gene sequencing (stool) – of bacterial DNA
  • Metabolomic profiling (Urine and stool) – using Nuclear Magnetic Resonance (NMR) and mass spectrometry
  E) Collection of dietary history information for the previous 72 hr period

  Study Duration: 2 years (single visit).

• REC name

  London - South East Research Ethics Committee

• REC reference

  15/LO/0037

• Date of REC Opinion

  5 Mar 2015

• REC opinion

  Further Information Favourable Opinion